CDIO · NASDAQ
Cardio Diagnostics Holdings (CDIO) Stock Price & Fundamentals
Cardio Diagnostics Holdings (CDIO) closed at $786.45 on Oct 9, 2026, up 1.08% from the previous close of $778.02.
Share price, past year
1Y −0.80%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $786.45 |
| Sep 30, 2026 | $779.26 |
| Aug 31, 2026 | $781.85 |
| Jul 31, 2026 | $779.97 |
| Jun 30, 2026 | $728.54 |
| May 29, 2026 | $700.85 |
| Apr 30, 2026 | $712.57 |
| Mar 31, 2026 | $747.17 |
| Feb 27, 2026 | $770.38 |
| Jan 30, 2026 | $768.21 |
| Dec 31, 2025 | $787.51 |
| Nov 28, 2025 | $775.04 |
| Oct 31, 2025 | $776.13 |
Key statistics
- Market cap
- $2.33B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.91
- Revenue (TTM)
- $14.45K
- Net income (TTM)
- −$6.47M
- Shares outstanding
- 3M
- Dividend yield
- —
- 52-week range
- $677.24 – $803.90
Cardio Diagnostics Holdings's market cap is $2.33B, based on a share price of $786.45 and 3M shares outstanding as of Jun 30, 2026.
Financials
Cardio Diagnostics Holdings reported revenue of $14.83K for fiscal 2025, down 57.51% from fiscal 2024.
Cardio Diagnostics Holdings reported a net loss of $6.50M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $14.83K | −57.5% | −$6.50M | −43,832.5% | −$3.71 | −$5.91M |
| FY2024ended Dec 31, 2024 | $34.89K | +104.5% | −$8.38M | −24,028.2% | −$9.35 | −$5.21M |
| FY2023ended Dec 31, 2023 | $17.07K | +1,696.3% | −$8.38M | −49,087.8% | −$0.66 | −$6.25M |
| FY2022ended Dec 31, 2022 | $950.00 | +5.4% | −$4.66M | −490,630.0% | −$1.51 | — |
| FY2021ended Dec 31, 2021 | $901.00 | — | −$620.45K | −68,862.2% | −$0.53 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $5.36K | −$1.50M | −$0.51 |
| Q1 FY2026ended Mar 31, 2026 | $2.68K | −$1.79M | −$0.63 |
| Q4 FY2025ended Dec 31, 2025 | $3.56K | −$1.47M | −$0.79 |
| Q3 FY2025ended Sep 30, 2025 | $2.86K | −$1.71M | −$0.98 |
| Q2 FY2025ended Jun 30, 2025 | $7.48K | −$1.68M | −$0.97 |
| Q1 FY2025ended Mar 31, 2025 | $940.00 | −$1.64M | −$0.97 |
| Q4 FY2024ended Dec 31, 2024 | $4.51K | −$1.52M | $0.02 |
| Q3 FY2024ended Sep 30, 2024 | $6.58K | −$1.41M | −$1.73 |
Company profile
- Name
- Cardio Diagnostics Holdings, Inc.
- Ticker
- CDIO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- In Vitro & In Vivo Diagnostic Substances
- Headquarters
- 311 W. Superior Street, Suite 444, Chicago, IL 60645
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001870144
Recent SEC filings
- Sep 18, 2026
- Aug 20, 2026
- Aug 7, 2026
- May 15, 2026
- Mar 13, 2026
- Feb 19, 2026
- Nov 12, 2025
- Oct 15, 2025
Frequently asked questions
What is Cardio Diagnostics Holdings's stock price?
Cardio Diagnostics Holdings (CDIO) closed at $786.45 on Oct 9, 2026, up 1.08% from the previous close of $778.02.
What is Cardio Diagnostics Holdings's market cap?
Cardio Diagnostics Holdings's market cap is $2.33B, based on a share price of $786.45 and 3M shares outstanding as of Jun 30, 2026.
How much revenue does Cardio Diagnostics Holdings make?
Cardio Diagnostics Holdings reported revenue of $14.83K for fiscal 2025, down 57.51% from fiscal 2024.
Does Cardio Diagnostics Holdings pay a dividend?
Cardio Diagnostics Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Cardio Diagnostics Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures